EU Launches ‘Structured Dialog’ To Thrash Out Supply Chain Concerns

First Meeting Slated For 25 March

The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.

Fill the Gaps red sign with sun background
An EU initiative aims to address medicine supply chain issues • Source: Shutterstock

The European Commission says it plans to produce a set of concrete measures to address the supply chain issues that can lead to drug shortages in the EU by the end of this year, under what it calls a “structured dialogue” with stakeholders from the pharmaceutical industry and patient and health professional organizations.

The dialogue, which was launched on 26 February, is the first step in implementing the EU’s Pharmaceutical Strategy, which was...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography